Alambic Investment Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-26,200
| Closed | -$440K | – | 423 |
|
|
2018
Q2 | $440K | Buy |
+26,200
| New | +$440K | 0.12% | 227 |
|
|
2017
Q4 | – | Sell |
-26,923
| Closed | -$331K | – | 561 |
|
|
2017
Q3 | $331K | Sell |
26,923
-15,619
| -37% | -$192K | 0.04% | 391 |
|
|
2017
Q2 | $356K | Sell |
42,542
-152,488
| -78% | -$1.28M | 0.04% | 432 |
|
|
2017
Q1 | $1.74M | Buy |
195,030
+21,800
| +13% | +$195K | 0.21% | 168 |
|
|
2016
Q4 | $1.52M | Sell |
173,230
-17,900
| -9% | -$157K | 0.27% | 127 |
|
|
2016
Q3 | $1.29M | Buy |
191,130
+45,342
| +31% | +$306K | 0.3% | 106 |
|
|
2016
Q2 | $519K | Buy |
145,788
+91,188
| +167% | +$325K | 0.13% | 271 |
|
|
2016
Q1 | $161K | Buy |
54,600
+18,700
| +52% | +$55.1K | 0.05% | 416 |
|
|
2015
Q4 | $151K | Buy |
+35,900
| New | +$151K | 0.09% | 308 |
|